Cargando…

“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care

BACKGROUND: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. PURPOSE: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthes, Anni, Wolf, Florian, Bleidorn, Jutta, Markwart, Robby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375998/
https://www.ncbi.nlm.nih.gov/pubmed/35975172
http://dx.doi.org/10.2147/PPA.S372366
_version_ 1784768069240881152
author Matthes, Anni
Wolf, Florian
Bleidorn, Jutta
Markwart, Robby
author_facet Matthes, Anni
Wolf, Florian
Bleidorn, Jutta
Markwart, Robby
author_sort Matthes, Anni
collection PubMed
description BACKGROUND: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. PURPOSE: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. METHODS: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW(TM) COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann–Whitney U-test to reveal differences in cost contribution depending on the test result. RESULTS: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0€ and 100€ (interquartile range = 10–25€) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. CONCLUSION: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients’ behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients’ expectations in future situation.
format Online
Article
Text
id pubmed-9375998
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93759982022-08-15 “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care Matthes, Anni Wolf, Florian Bleidorn, Jutta Markwart, Robby Patient Prefer Adherence Original Research BACKGROUND: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. PURPOSE: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. METHODS: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW(TM) COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann–Whitney U-test to reveal differences in cost contribution depending on the test result. RESULTS: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0€ and 100€ (interquartile range = 10–25€) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. CONCLUSION: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients’ behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients’ expectations in future situation. Dove 2022-08-10 /pmc/articles/PMC9375998/ /pubmed/35975172 http://dx.doi.org/10.2147/PPA.S372366 Text en © 2022 Matthes et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Matthes, Anni
Wolf, Florian
Bleidorn, Jutta
Markwart, Robby
“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title_full “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title_fullStr “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title_full_unstemmed “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title_short “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
title_sort “it was very comforting to find out right away.” – patient perspectives on point-of-care molecular sars-cov-2 testing in primary care
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375998/
https://www.ncbi.nlm.nih.gov/pubmed/35975172
http://dx.doi.org/10.2147/PPA.S372366
work_keys_str_mv AT matthesanni itwasverycomfortingtofindoutrightawaypatientperspectivesonpointofcaremolecularsarscov2testinginprimarycare
AT wolfflorian itwasverycomfortingtofindoutrightawaypatientperspectivesonpointofcaremolecularsarscov2testinginprimarycare
AT bleidornjutta itwasverycomfortingtofindoutrightawaypatientperspectivesonpointofcaremolecularsarscov2testinginprimarycare
AT markwartrobby itwasverycomfortingtofindoutrightawaypatientperspectivesonpointofcaremolecularsarscov2testinginprimarycare